DOCS vs. P

Last updated Jun 13, 2026

DOCS (Doximity, Inc.) and P (Everpure, Inc.) are both stocks. DOCS operates in Health Information Services (Healthcare), while P operates in Computer Hardware (Technology). Over the past 3 years, DOCS returned -14.86%/yr vs 25.48%/yr for P. At a 0.36 correlation, their price movements are largely independent.

Performance

DOCS vs. P - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Doximity, Inc. (DOCS) and Everpure, Inc. (P). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DOCS achieves a -54.74% return, which is significantly lower than P's 7.91% return.

DOCS

• 1D: 0.10%
• 1M: -14.32%
• YTD: -54.74%
• 6M: -54.30%
• 1Y: -64.81%
• 3Y*: -14.86%
• 5Y*: —
• 10Y*: —

P

• 1D: 4.28%
• 1M: -14.36%
• YTD: 7.91%
• 6M: 1.39%
• 1Y: 32.70%
• 3Y*: 25.48%
• 5Y*: 30.55%
• 10Y*: 21.03%

*Multi-year figures are annualized to reflect compound growth (CAGR)

DOCS vs. P - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
DOCS Doximity, Inc.	-54.74%	-17.06%	90.41%	-16.45%	-33.05%	21.76%
P Everpure, Inc.	7.91%	9.08%	72.27%	33.26%	-17.79%	64.98%

Correlation

The correlation between DOCS and P is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.22
Correlation (3Y) Calculated over the trailing 3-year period	0.31
Correlation (All Time) Calculated using the full available price history since Jun 24, 2021	0.36

The correlation between DOCS and P shifts across timeframes, from 0.22 (1 year) to 0.36 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap DOCS : $3.91B P : $23.61B
EPS DOCS : $0.98 P : $0.56
PE Ratio DOCS : 20.35 P : 129.77
PEG Ratio DOCS : 1.74 P : 4.02
PS Ratio DOCS : 6.19 P : 6.67
Total Revenue (TTM) DOCS : $644.86M P : $3.66B
Gross Profit (TTM) DOCS : $574.54M P : $2.58B
EBITDA (TTM) DOCS : $245.76M P : $306.67M

Return for Risk

DOCS vs. P — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DOCS

DOCS Risk / Return Rank: 5
DOCS Sharpe Ratio Rank: 2
DOCS Sortino Ratio Rank: 3
DOCS Omega Ratio Rank: 2
DOCS Calmar Ratio Rank: 9
DOCS Martin Ratio Rank: 8

P

P Risk / Return Rank: 60
P Sharpe Ratio Rank: 59
P Sortino Ratio Rank: 59
P Omega Ratio Rank: 62
P Calmar Ratio Rank: 60
P Martin Ratio Rank: 58

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DOCS vs. P - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Doximity, Inc. (DOCS) and Everpure, Inc. (P). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	DOCS	P	Difference
Sharpe ratio: Return per unit of total volatility	-1.20	0.48	-1.68
Sortino ratio: Return per unit of downside risk	-1.96	1.12	-3.08
Omega ratio: Gain probability vs. loss probability	0.72	1.16	-0.44
Calmar ratio: Return relative to maximum drawdown	-0.85	0.78	-1.63
Martin ratio: Return relative to average drawdown	-1.43	1.50	-2.92

DOCS vs. P - Sharpe Ratio Comparison

The current DOCS Sharpe Ratio is -1.20, which is lower than the P Sharpe Ratio of 0.48. The chart below compares the historical Sharpe Ratios of DOCS and P, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

DOCS vs. P - Drawdown Comparison

The maximum DOCS drawdown since its inception was -82.35%, which is greater than P's maximum drawdown of -69.43%. Use the drawdown chart below to compare losses from any high point for DOCS and P.

Drawdown Indicators

	DOCS	P	Difference
Max Drawdown Largest peak-to-trough decline	-82.35%	-69.43%	-12.92%
Max Drawdown (1Y) Largest decline over 1 year	-76.03%	-42.26%	-33.77%
Max Drawdown (3Y) Largest decline over 3 years	-78.34%	-48.63%	-29.71%
Max Drawdown (5Y) Largest decline over 5 years	—	-48.63%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-69.43%	—
Current Drawdown Current decline from peak	-80.36%	-26.74%	-53.62%
Average Drawdown Average peak-to-trough decline	-57.18%	-24.44%	-32.74%
Ulcer Index Depth and duration of drawdowns from previous peaks	45.49%	21.89%	+23.60%

Volatility

DOCS vs. P - Volatility Comparison

Doximity, Inc. (DOCS) has a higher volatility of 29.57% compared to Everpure, Inc. (P) at 26.95%. This indicates that DOCS's price experiences larger fluctuations and is considered to be riskier than P based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	DOCS	P	Difference
Volatility (1M) Calculated over the trailing 1-month period	29.57%	26.95%	+2.62%
Volatility (6M) Calculated over the trailing 6-month period	44.93%	45.02%	-0.09%
Volatility (1Y) Calculated over the trailing 1-year period	54.14%	68.32%	-14.18%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	70.07%	52.74%	+17.33%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	70.07%	51.15%	+18.92%

Dividends

DOCS vs. P - Dividend Comparison

Neither DOCS nor P has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

DOCS vs. P - Profitability Comparison

The chart below illustrates the profitability comparison between Doximity, Inc. and Everpure, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

DOCS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Doximity, Inc. reported a gross profit of 125.97M and revenue of 145.37M. Therefore, the gross margin over that period was 86.7%.

P - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Everpure, Inc. reported a gross profit of 536.15M and revenue of 778.49M. Therefore, the gross margin over that period was 68.9%.

DOCS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Doximity, Inc. reported an operating income of 24.83M and revenue of 145.37M, resulting in an operating margin of 17.1%.

P - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Everpure, Inc. reported an operating income of -31.17M and revenue of 778.49M, resulting in an operating margin of -4.0%.

DOCS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Doximity, Inc. reported a net income of 19.11M and revenue of 145.37M, resulting in a net margin of 13.2%.

P - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Everpure, Inc. reported a net income of -14.00M and revenue of 778.49M, resulting in a net margin of -1.8%.

Frequently Asked Questions

Can I hold both DOCS and P in my portfolio?

DOCS and P have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, DOCS or P?

DOCS has higher volatility (29.57%) compared to P (26.95%). In terms of maximum drawdown, DOCS dropped -82.35% vs P's -69.43%.

Which has better risk-adjusted returns?

P currently has the higher Sharpe Ratio (0.48 vs -1.20), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.